You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARRY-142886

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Tumor, Cancer Trial in Netherlands, United Kingdom, United States (AZD6244)

Active, not recruiting
  • Tumor
  • Cancer
  • Aurora, Colorado
  • +3 more
Dec 22, 2022

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

Advanced Cancer Trial in Aurora, Rochester, Philadelphia (ARRY-142886, MEK inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-142886, MEK inhibitor; oral
  • Aurora, Colorado
  • +2 more
Oct 12, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Biopsy
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 29, 2022

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib 75 mg, Docetaxel 75

Completed
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib 75 mg
  • +3 more
  • Santa Monica, California
  • +50 more
Nov 22, 2022

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

Completed
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Los Angeles, California
  • +48 more
Dec 2, 2020

Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

Terminated
Has Results
  • Non-Metastatic Adenocarcinoma of the Rectum
  • Radiation Therapy
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021

Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Phase Ib ARRY-614 + nivolumab
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2022

LMNA-Related Dilated Cardiomyopathy Trial in United States (ARRY-371797, p38 inhibitor, oral)

Completed
Has Results
  • LMNA-Related Dilated Cardiomyopathy
  • ARRY-371797, p38 inhibitor, oral
  • Aurora, Colorado
  • +3 more
Mar 3, 2022

Healthy Trial in Madison (PF-07265803)

Completed
  • Healthy
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Jul 10, 2022

Colonic Tumors, Cancer of the Colon, Colon Cancer Trial run by the NCI (Cetuximab, AZD6244)

Completed
  • Colonic Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

Active, not recruiting
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Birmingham, Alabama
  • +21 more
Dec 4, 2021

Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

Terminated
Has Results
  • Advanced Solid Tumors
  • Los Angeles, California
  • +29 more
May 21, 2022

Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)

Completed
Has Results
  • Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
  • Glasgow, United Kingdom
  • +3 more
Mar 12, 2018

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +3 more
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Dental Pain Trial in Austin, Salt Lake City (Placebo; oral, ARRY-371797, p38 inhibitor; oral, Celecoxib, COX-2 inhibitor; oral)

Completed
  • Dental Pain
  • Placebo; oral
  • +2 more
  • Austin, Texas
  • +1 more
Feb 7, 2021

Dental Pain Trial in San Marcos, Salt Lake City (ARRY-371797, p38 inhibitor; oral, Placebo; oral)

Completed
  • Dental Pain
  • ARRY-371797, p38 inhibitor; oral
  • Placebo; oral
  • San Marcos, Texas
  • +1 more
Feb 17, 2021

Healthy Trial in Madison (ARRY-502, Placebo)

Completed
  • Healthy
  • Madison, Wisconsin
    (unnamed)
Sep 30, 2020

Rheumatoid Arthritis Trial in Worldwide (ARRY-438162, MEK inhibitor; oral, Placebo; oral)

Completed
Has Results
  • Rheumatoid Arthritis
  • ARRY-438162, MEK inhibitor; oral
  • Placebo; oral
  • Spartanburg, South Carolina
  • +34 more
Nov 15, 2020